Events

December 2019

January 2020

February 2020

December 2019

Cures Acceleration Network (CAN) Review Board Virtual Meeting

Dec. 13, 2019
11 a.m. to 1:30 p.m. ET

The Cures Acceleration Network (CAN) Review Board will convene a virtual meeting by teleconference, in open session on Friday, Dec. 13, 2019, at 11:00 a.m. ET. Gilbert “Lynn” Marks, M.D., CAN Review Board chair, will lead the meeting. In accordance with Public Law 92-463, the session will be open to the public. For more information about the CAN Review Board, visit the Cures Acceleration Network Review Board page of this site.

Agenda (PDF - 149KB) • Register for WebEx Access

NCATS Day 2019: Conversations on Responsible Data Sharing

Dec. 17, 2019
9 a.m. to 4:15 p.m. ET

National Institutes of Health (Main Campus)
Natcher Conference Center (Bldg. 45)
45 Center Drive, Rooms E1/E2
Bethesda, Maryland 20892

Save the date for NCATS Day 2019. This event provides a forum for sharing and reflecting upon patient and community needs — as well as best practices and perspectives in addressing those needs. The full-day event will feature presentations, interactive discussion and activities, fostering an open dialogue for diverse participants to discuss common roadblocks to translational science and brainstorm ideas for improvement.

Patients and patient advocates, caregivers, community partners, community health engagement professionals, clinical and translational researchers, NCATS staff and others are encouraged to attend.

Admission is free, but space is limited. So, please register early. Join the conversation on Dec. 17, 2019, on Twitter using #NCATSDay.

WebsiteAgendaRegistrationVideocast

January 2020

Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies

Jan. 28–29, 2020
8 a.m. to 5 p.m. ET

National Institutes of Health (Main Campus)
Natcher Conference Center (Bldg. 45), Ruth L. Kirschstein Auditorium
45 Center Drive
Bethesda, Maryland 20892

Current adeno-associated virus (AAV) manufacturing capacity cannot keep pace with the demand for AAV gene therapy clinical trials. NCATS and the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA) will host a workshop on the NIH main campus on January 28–29 to explore obstacles and identify opportunities for expanding the capacity of AAV manufacturing.

Website • RegistrationSubmit Abstracts • Videocast

February 2020

Rare Disease Day at NIH

Feb. 28, 2020
8:30 a.m. to 4:30 p.m. ET

National Institutes of Health (Main Campus)
Natcher Conference Center (Bldg. 45)
45 Center Drive
Bethesda, Maryland 20892

Sponsored by the National Center for Advancing Translational Sciences (NCATS) and Clinical Center (CC) at the National Institutes of Health (NIH), Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations under way to address scientific challenges and to advance new treatments.

Admission is free, and the event is open to the public, including patients, patient advocates, health care providers, researchers, industry representatives and government employees. In association with Global Genes®, participants are encouraged to wear their favorite pair of jeans.

RegistrationVideocast